KMK Consulting, Inc.
Pharma analytics and consulting services
Manager/Associate Director, Commercial Analytics & Operations - Sales Operations
About the job
- A bachelor's degree in Computer Science or a related field.
- At least 7 years of business experience in analytics, particularly within pharmaceutical commercial analytics and operations.
- Extensive experience in Salesforce Effectiveness, Sales Planning, and Incentive Compensation, with a focus on oncology or rare disease.
- Proven experience managing both onshore and offshore teams.
- Experience in account management and business development.
- Proficiency in SQL and data visualization tools such as Power BI or Tableau.
- Lead projects related to oncology and rare disease Salesforce Effectiveness and Sales Planning.
- Collaborate with the leadership team to develop and design Salesforce Effectiveness strategies and planning that enhance sales performance.
- Provide analytical support in Salesforce alignment, call planning and targeting, and incentive compensation.
- Utilize programming and software to develop processes supporting Salesforce Effectiveness, Sales Planning, and Incentive Compensation.
- Generate reports on call planning, incentive compensation, and alignment.
- Experience with SAS, Python, or R.
About the company
KMK Consulting, Inc. provides analytics and consulting for life sciences, focusing on pharma and biotech. Its offerings blend software and advisory services to improve planning, commercialization, and value demonstration across the product lifecycle, including Commercial Analytics, HEOR, RWE, Advanced Analytics, Market Research, and Data Services, with flexible delivery models (project work, SaaS, or on-site teams). Customers use KMK to optimize sales force effectiveness, design incentive programs, and generate evidence for drug approval and reimbursement. In 2026 KMK was acquired by Tredence to combine pharma expertise with AI and data engineering, expanding capabilities in research, development, supply chain, and commercial operations.
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
Morris Plains, New Jersey
Founded
2000
Get referred to KMK Consulting, Inc.
See people who can refer or advise you
Simplify's Take
What believers are saying
- Tredence targets healthcare and life sciences at 25% of revenue by 2028.
- June 2026 buyer messaging highlighted cross-selling AI into KMK's pharma client base.
- KMK's Great Place to Work score hit 95% in April 2026.
What critics are saying
- KMK's acquisition by Tredence in June 2026 triggers costly integration and culture clashes.
- Eight-top-ten-pharma concentration leaves revenue exposed if Pfizer, Novartis, or peers rebid.
- Agentic AI services commoditize quickly; Tredence must win fast or lose to Accenture.
What makes KMK Consulting, Inc. unique
- KMK serves eight of the top ten pharma companies, per June 2026 deal materials.
- Its niche spans RWE, HEOR, commercial analytics, and market research across product lifecycles.
- Tredence bought KMK on June 22, 2026 to pair domain depth with agentic AI.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Company News
/PRNewswire/ -- Tredence, the world's leading AI and data science solutions company, today announced the acquisition of KMK Consulting, a specialized analytics...